Medical injection molder Phillips-Medisize LLC is expanding its manufacturing capacity in Poland, China and the U.S. to meet demand for drug delivery, diagnostic and medical technology products.
The Hudson, Wis.-based company will expand its product design, development and manufacturing capabilities with new and expanded production facilities and research and development centers, an Oct. 19 news release said.
"We continually invest in new talent and technologies that increase the capacity and capabilities of Phillips-Medisize across the entire value chain," Paul Chaffin, president of medical and pharmaceutical solutions at Molex, said in the release. "Our expanded global reach and resources will enable us to solve complex development and manufacturing challenges while meeting escalating customer demands."
Expected to open in 2022, Phillips-Medisize is building a new medical manufacturing facility in Katowice, Poland, to meet growing demands from its customers in continental Europe, the release said.
The company has started an initiative with iCredence MedSystems to ramp up production of its Credence Companion-brand and Dual Chamber Reconstitution products at the Phillips-Medisize Letterkenny, Ireland, site and the new facility in Poland.
"The opportunity to scale production in close proximity to our operations and European customers will accelerate market delivery of our innovative solutions to meet the needs of our pharma customers and their end-users," Jeff Tillack, chief operating officer at Credence MedSystems, said in the release.
Phillips-Medisize is also currently renovating an existing Molex production facility in Little Rock, Ark., to meet U.S. demand for diagnostic device manufacturing, the company said. It is also expanding production capacity in Suzhou, China, to serve both global and regional pharmaceutical and medical technology customers.
Phillips-Medisize did not immediately respond to questions from Plastics News.
When the expansions are complete, the company will have about three million square feet of manufacturing space and R&D facilities worldwide, the release said. It will also have 600,000 square feet of Class 7 and 8 clean rooms.
The expansions are expected to add at least 1,000 employees globally "over the next couple of years," it said.
Phillips-Medisize is No. 18 in Plastics News' ranking of North American injection molders, with estimated sales of $485 million.